Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Genetic analysis of Cashmere goats identified key genes for wool, reproduction, and high-altitude adaptation.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

People with alopecia areata are more likely to have other immune-related conditions.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Blocking IL-17a can improve age-related smell loss in mice.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

RXRα is crucial for proper immune response and links diet to immune function.